HN2002000350A - Combinacion de una forma de farmaco cristalina y una sal de tiotropio - Google Patents

Combinacion de una forma de farmaco cristalina y una sal de tiotropio

Info

Publication number
HN2002000350A
HN2002000350A HN2002000350A HN2002000350A HN2002000350A HN 2002000350 A HN2002000350 A HN 2002000350A HN 2002000350 A HN2002000350 A HN 2002000350A HN 2002000350 A HN2002000350 A HN 2002000350A HN 2002000350 A HN2002000350 A HN 2002000350A
Authority
HN
Honduras
Prior art keywords
salt
combination
tiotropio
farmaco
crystal
Prior art date
Application number
HN2002000350A
Other languages
English (en)
Original Assignee
Inc Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inc Pfizer filed Critical Inc Pfizer
Priority to HN2002000350A priority Critical patent/HN2002000350A/es
Publication of HN2002000350A publication Critical patent/HN2002000350A/es

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A UNA COMBINACION DE UNA FORMA CRISTALINA DE 6-[(2,2- DIFENILETIL)AMINO] - 9- (N-ETIL-B-D-RIBOFURANOSIL - URONAMIDA)-N- (2- {N´ -[ 1-(2-PIRIDIL) - 4- PIPERIDIL] UREIDO} ETIL)-9H-PURIN-2-CARBOXAMIDA Y A UNA SAL DE TIOTROPIO.
HN2002000350A 2002-12-03 2002-12-03 Combinacion de una forma de farmaco cristalina y una sal de tiotropio HN2002000350A (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HN2002000350A HN2002000350A (es) 2002-12-03 2002-12-03 Combinacion de una forma de farmaco cristalina y una sal de tiotropio

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HN2002000350A HN2002000350A (es) 2002-12-03 2002-12-03 Combinacion de una forma de farmaco cristalina y una sal de tiotropio

Publications (1)

Publication Number Publication Date
HN2002000350A true HN2002000350A (es) 2003-07-23

Family

ID=53183918

Family Applications (1)

Application Number Title Priority Date Filing Date
HN2002000350A HN2002000350A (es) 2002-12-03 2002-12-03 Combinacion de una forma de farmaco cristalina y una sal de tiotropio

Country Status (1)

Country Link
HN (1) HN2002000350A (es)

Similar Documents

Publication Publication Date Title
WO2003079986A3 (en) Uracil derivatives as inhibitors of tnf-alpha converting enzyme (tace) and matrix metalloproteinases
PE20070241A1 (es) Sales de 4-metil-n-[3-(4-metil-imidazo-1-lil)-5-triflurometil-fenil]-3-(4-piridi-3-nil-pirimidi-2-nilamino)-benzamida
WO2007048065A3 (en) Pyrimidinones as casein kinase ii (ck2) modulators
WO2003053941A3 (en) Barbituric acid derivatives as inhibitors of tnf-alpha converting enzyme (tace) and/or matrix metalloproteinases
WO2004033632A3 (en) Hydantoin derivatives as inhibitors of matrix metalloproteinases and/or tnf-alpha converting enzyme (tace)
HK1028599A1 (en) Crystal modification of a n-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use
AP2006003551A0 (en) Combinations of a pyrimidine containing NNRTI withRT inhibitors.
ZA200501418B (en) Benzenesulfonate salts of 4-fluoro-2-cyanopyrrolidine derivatives
IL172006A0 (en) Novel crystalline forms of valacyclovir hydrochloride
AU2003232960A1 (en) 4-4(methylpiperazin-1-ylmethyl)-n-(4-methyl-3-(pyridin-3-yl)pyrimidin-2-ylamino)phenyl)-benzamide for treating mutated-ret kinase associated diseases
HK1072192A1 (en) Treatment of rheumatoid arthritis using imatinib
WO2003016248A3 (en) Bicyclic hydroxamates as inhibitors of matrix metalloproteinases and/or tnf-$g(a) converting enzyme (tace)
IL161842A0 (en) 2-Amino-4-heteroarylethyl-thiazoline derivatives and their use as inhibitors of inducible no-synthase
CY1106822T1 (el) Κρυσταλλικη μορφη ενος παραγωγου ριβοφουρανοσυλουροναμιδιου, αγωνιστης υποδοχεα α2α αδενοσινης του ανθρωπου
HN2002000350A (es) Combinacion de una forma de farmaco cristalina y una sal de tiotropio
AU2003232719A1 (en) Novel crystalline forms of valacyclovir hydrochloride
AU2003289995A1 (en) Anhydrous crystalline form of valacyclovir hydrochloride
ATE343940T1 (de) Perlenkette
DOP2002000527A (es) Forma de farmaco cristalina.
DOP2002000526A (es) Combinacion de una forma de farmaco cristalina y una sal de tiotropio.
UY27569A1 (es) Combinación de una forma de fármaco cristalina y una sal de tiotropio
TH89054EX (th) หน้าปัดนาฬิกา
TH89051EX (th) หน้าปัดนาฬิกา
TH77038B (th) ลวดลายหน้าปัดนาฬิกา
AU2003226379A1 (en) Treatment of parkinson's disease with cyclooxygenase-2 (cox 2) inhibitor(s)